ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Patient-Driven Gene Therapy Company ReflectionBio Receives Orphan Drug Designation From U.S. FDA For the Treatment of Bietti's Crystalline Dystrophy (BCD)
November 26, 2018Reflection Biotechnologies Limited ("ReflectionBio"), a gene therapy company committed to the research and development... -
ReflectionBio Receives Orphan Drug Designation from FDA
August 29, 2018Reflection Biotechnologies Limited (ReflectionBio) announced the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to ReflectionBio's RBIO-101 program (AAV.CYP4V2), an AAV-based gene therapy product for treating Bietti's Crystall
Pharma Sources Insight January 2025
